Molina Healthcare, Inc. reported a GAAP loss per diluted share of $3.15 and an adjusted loss per diluted share of $2.75 for the fourth quarter of 2025. The company's full year 2025 GAAP earnings per diluted share was $8.92 and adjusted earnings per diluted share was $11.03. The fourth quarter results were significantly impacted by unfavorable retroactive revenue items.
Fourth quarter 2025 GAAP loss per diluted share was $3.15, burdened by approximately $2.00 of unfavorable retroactive revenue items.
Adjusted net income for the full year 2025 was $11.03 per diluted share.
The company issued full year 2026 earnings guidance with expected premium revenue of approximately $42 billion and adjusted earnings of at least $5.00 per diluted share.
New store embedded earnings are now over $11.00 per diluted share.
Molina Healthcare expects full year 2026 premium revenue of approximately $42.2 billion and adjusted earnings of at least $5.00 per diluted share. The guidance is impacted by the implementation of a new Florida CMS Medicaid contract and underperformance in the traditional Medicare Advantage Part D product.
Analyze how earnings announcements historically affect stock price performance